Delivery Order SPE2DB20D2002-SPE2DB25FL64Z
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,127.12 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day patches (3-count) on July 28, 2025, with a completion date of July 29, 2025. This firm fixed price, competitively awarded delivery order represents a routine pharmaceutical supply transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/DAY transdermal patches (three-patch supply) under a firm fixed-price contract valued at $1,214.87. The award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive delivery against an existing contract vehicle. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. XULANE is a contraceptive...
- The Defense Logistics Agency awarded a delivery order valued at $1,642.20 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day patches (quantity: 3) with a firm fixed price structure. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,040.92 to AmerisourceBergen Drug Corp for Xulane 150-35 microgram/day transdermal patches (three-count packaging). This firm fixed-price, non-set-aside contract was executed on August 7, 2025, with an ultimate completion date of August 8, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,428.13 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack units). This competitively awarded, non-set-aside delivery order reflects firm fixed pricing and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at three thousand four hundred three dollars and eighty-eight cents ($3,403.88) to Amerisourcebergen Drug Corporation for Xulane 150-35 mcg/day transdermal patches. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from July 13, 2023 through July 14, 2023. The delivery order was issued against an unspecified government-wide acquisition contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,988.76 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count). This firm fixed-price, competitively awarded contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,042.60 to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/day contraceptive patches (quantity of 3 units) on August 8, 2025, with a completion date of August 11, 2025. This firm fixed-price, competitively awarded delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,691.42 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count packaging). This is a firm fixed-price, non-set-aside contract with a completion date of August 8, 2025, and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the vendor's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $1,299.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (quantity: 3 units) on July 21, 2025, with completion scheduled for July 22, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger contract vehicle. The pharmaceutical product will be delivered to the company's distribution center in Conshohocken, Pennsylvania. This delivery...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL64ZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,276.00 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units). This firm fixed-price, non-set-aside delivery order was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Xulane is a combination hormonal contraceptive patch used for birth control and is part of the broader pharmaceutical supply requirements for federal military and healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies an extensive range of brand-name and generic medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract awards with DLA consistently demonstrate its capability to fulfill diverse medical supply needs through open competition and firm fixed-price arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 8/8/25 |